Activating adaptive cellular mechanisms of resistance following sublethal cytotoxic chemotherapy: implications for diagnostic microdosing (Q38186660)

30 August 2017

title

Activating adaptive cellular mechanisms of resistance following sublethal cytotoxic chemotherapy: implications for diagnostic microdosing (English)

1 reference

30 August 2017

Gregory T Wurz

1

1 reference

30 August 2017

Michael W DeGregorio

series ordinal

2

1 reference

30 August 2017

language of work or name

English

0 references

publication date

20 February 2014

1 reference

International Journal of Cancer

30 August 2017

published in

1 reference

30 August 2017

volume

136

1 reference

30 August 2017

issue

7

1 reference

30 August 2017

page(s)

1485-1493

1 reference

Acute induction of adriamycin-resistance in human colon carcinoma HT-29 cells exposed to a sublethal dose of adriamycin.

30 August 2017

cites work

1 reference

Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias

21 January 2018

1 reference

Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents.

21 January 2018

1 reference

Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells

21 January 2018

1 reference

Cisplatin selects for multidrug-resistant CD133 cells in lung adenocarcinoma by activating Notch signaling.

21 January 2018

1 reference

Cisplatin transiently up-regulates hHR23 expression through enhanced translational efficiency in A549 adenocarcinoma cells

21 January 2018

1 reference

The phase 0 microdosing concept

21 January 2018

1 reference

Microdosing: Current and The Future

21 January 2018

1 reference

Microdosing: a critical assessment of human data

21 January 2018

1 reference

Comparative requirements for exploratory clinical trials — eIND, eCTA and microdosing

21 January 2018

1 reference

Subattomole sensitivity in biological accelerator mass spectrometry

21 January 2018

1 reference

High-performance liquid chromatography accelerator mass spectrometry: correcting for losses during analysis by internal standardization

21 January 2018

1 reference

Predicting drug candidate victims of drug-drug interactions, using microdosing

21 January 2018

1 reference

Human Microdosing for The Prediction of Patient Response

21 January 2018

1 reference

A microdosing approach for characterizing formation and repair of carboplatin-DNA monoadducts and chemoresistance

21 January 2018

1 reference

Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer

21 January 2018

1 reference

Mechanisms of cancer drug resistance

21 January 2018

1 reference

ABC Transporters: From Microorganisms to Man

21 January 2018

1 reference

High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine

21 January 2018

1 reference

Toremifene and its metabolites enhance doxorubicin accumulation in estrogen receptor negative multidrug resistant human breast cancer cells

21 January 2018

1 reference

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

21 January 2018

1 reference

Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy.

21 January 2018

1 reference

Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer

21 January 2018

1 reference

The role of copper transporters in the development of resistance to Pt drugs

21 January 2018

1 reference

Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells

21 January 2018

1 reference

Highly tumorigenic lung cancer CD133 cells display stem-like features and are spared by cisplatin treatment

21 January 2018

1 reference

Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapy

21 January 2018

1 reference

Molecular mechanisms of cisplatin resistance

21 January 2018

1 reference

Platinum resistance: the role of DNA repair pathways

21 January 2018

1 reference

ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients

21 January 2018

1 reference

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

21 January 2018

1 reference

Role of Glutathione in the Regulation of Cisplatin Resistance in Cancer Chemotherapy

21 January 2018

1 reference

Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: a review

21 January 2018

1 reference

Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects.

21 January 2018

1 reference

The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines

21 January 2018

1 reference

Major vault protein LRP-related multidrug resistance

21 January 2018

1 reference

The ATP-dependent glutathione S-conjugate export pump

21 January 2018

1 reference

Expression of NDRG2 is related to tumor progression and survival of gastric cancer patients through Fas-mediated cell death

21 January 2018

1 reference

Knock-down of NDRG2 sensitizes cervical cancer Hela cells to cisplatin through suppressing Bcl-2 expression

21 January 2018

1 reference

Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma

21 January 2018

1 reference

Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma

21 January 2018

1 reference

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer

21 January 2018

1 reference

Differential modulation of P-glycoprotein transport by protein kinase inhibition

21 January 2018

1 reference

Involvement of protein kinase in environmental stress-induced activation of human multidrug resistance 1 (MDR1) gene promoter

21 January 2018

1 reference

Purification and biochemical characterization of a novel protein—tongue cancer chemotherapy resistance-associated protein1 (TCRP1)

21 January 2018

1 reference

The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy

21 January 2018

1 reference

Tissue platinum concentration and tumor response in non-small-cell lung cancer

21 January 2018

1 reference

Membrane transporters as determinants of the pharmacology of platinum anticancer drugs.

21 January 2018

1 reference

Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals

21 January 2018

1 reference

Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy

21 January 2018

1 reference

A re-evaluation of the role of hCTR1, the human high-affinity copper transporter, in platinum-drug entry into human cells

21 January 2018

1 reference

Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma

21 January 2018

1 reference

The resurgence of platinum-based cancer chemotherapy

21 January 2018

1 reference

DNA damage recognition and nucleotide excision repair in mammalian cells.

21 January 2018

1 reference

ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer.

21 January 2018

1 reference

A new step ahead for the consideration of ERCC1 as a candidate biomarker to select NSCLC patients for the treatment of cetuximab in combination with cisplatin

21 January 2018

1 reference

Resistance to chemotherapy: short-term drug tolerance and stem cell-like subpopulations.

21 January 2018

1 reference

The therapeutic promise of the cancer stem cell concept

21 January 2018

1 reference

Tumorigenic stem and progenitor cells: implications for the therapeutic index of anti-cancer agents

21 January 2018

1 reference

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden

21 January 2018

1 reference

Premature senescence is a major response to DNA cross-linking agents in BRCA1-defective cells: implication for tailored treatments of BRCA1 mutation carriers.

21 January 2018

1 reference

Restriction of cisplatin induction of acute apoptosis to a subpopulation of cells in a three-dimensional carcinoma culture model

21 January 2018

1 reference

Cellular senescence and cancer chemotherapy resistance

21 January 2018

1 reference

Reversal of human cellular senescence: roles of the p53 and p16 pathways

21 January 2018

1 reference

Reversal of senescence in mouse fibroblasts through lentiviral suppression of p53.

21 January 2018

1 reference

Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response

21 January 2018

1 reference

Plasma pharmacokinetic evaluation of cytotoxic agents radiolabelled with positron emitting radioisotopes.

21 January 2018

1 reference

Toward prediction of efficacy of chemotherapy: a proof of concept study in lung cancer patients using [¹¹C]docetaxel and positron emission tomography.

21 January 2018

1 reference

Phase 0 microdosing PET study using the human mini antibody F16SIP in head and neck cancer patients

21 January 2018

1 reference

Pharmacologic validation of human tumor clonogenic assays based on pleiotropic drug resistance: implications for individualized chemotherapy and new drug screening programs

21 January 2018

1 reference

Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity

21 January 2018

1 reference

He's not going to talk about in vitro predictive assays again, is he?

21 January 2018

1 reference

AMD473 (ZD0473) exhibits marked in vitro anticancer activity in human tumor specimens taken directly from patients

21 January 2018

1 reference

DNA Repair Capacity in Peripheral Lymphocytes Predicts Survival of Patients With Non–Small-Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy

21 January 2018

1 reference

Identification of postoperative adjuvant chemotherapy responders in non-small cell lung cancer by novel biomarker

21 January 2018

1 reference

Genetic modifiers of carcinogen DNA adducts in target lung and peripheral blood mononuclear cells

21 January 2018

1 reference

RETRACTED ARTICLE: TCRP1 promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathway

21 January 2018

1 reference

Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28773

1 reference

30 August 2017

1 reference